Faber, J
10043  Ergebnisse:
?
 
?
2

Assessing best practices for opioid prescribing to children..:

Tomb, L ; Faber, A ; Ebeling, M.
The American Journal of the Medical Sciences.  367 (2024)  - p. S423 , 2024
 
?
 
?
6

Faber: A Hardware/SoftWare Toolchain for Image Registration:

D'Arnese, Eleonora ; Conficconi, Davide ; Sozzo, Emanuele Del...
IEEE Transactions on Parallel and Distributed Systems.  34 (2023)  1 - p. 291-303 , 2023
 
?
7

Novel approach to depression in ischemic heart disease: att..:

Gjedde, A ; Bibby, B ; Gyntelberg, F...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
 
?
 
?
9

129P Naxitamab efficacy in patients with refractory/relapse..:

Kushner, B. ; Mora, J. ; Chan, G....
Immuno-Oncology and Technology.  20 (2023)  - p. 100601 , 2023
 
?
10

OC 07.4 HMB-001, a Bispecific anti-FVIIa/anti-TLT-1 Antibod..:

Ostergaard, H. ; Ferraresi, P. ; Baroni, M....
Research and Practice in Thrombosis and Haemostasis.  7 (2023)  - p. 100474 , 2023
 
?
11

Mechanical dyssynchrony, a novel marker to predict long-ter..:

Ahmed, M A ; Sohns, C ; Rudolph, V...
European Heart Journal.  43 (2022)  Supplement_2 - p. , 2022
 
?
12

109P Impact of anti-drug antibody (ADA) on naxitamab effica..:

Kushner, B. ; Chan, G.C. ; Morgenstern, D.A....
Immuno-Oncology and Technology.  16 (2022)  - p. 100213 , 2022
 
?
13

62MO Naxitamab pivotal clinical trial planned interim analy..:

Mora, J. ; Chan, G.C. ; Morgenstern, D.A....
Immuno-Oncology and Technology.  16 (2022)  - p. 100167 , 2022
 
1-15